Relationship between polymorphisms of tumor necrosis factor-alpha and Kazakh esophageal squamous cell cancer in Xinjiang

World Chinese Journal of Digestology

Volumn 15, Issue 20, 2007, Pages 2236-2241

  Zhang, Hai Yang ^a   Zhang, Hui Min ^a   Chen, Ling ^a   Yang, Lan ^a   Li, Hong An ^a   Jiang, Jin Fang ^a   Qin, Jiang Mei ^a   Yang, Lei ^a   Zhang, Guo Chang ^a   Li, Feng ^a,b  

^a SHIHEZI UNIVERSITY   (China)

^b Shihezi Medical University   (China)

Author keywords

Esophageal cancer; Gene polymorphism; Kazakh; Polymerase chain reaction restriction fragment length polymorphism; Tumor necrosis factor

Indexed keywords

AMINO ACID; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER PATIENT; CHINA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

EID: 34548807587     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Chariot C, Rigal D, Coiffier B, Salles G. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91: 3574-3581
2. Chinese source
3. Chinese source
4. Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, Pereira D, Moutinho J, Canedo P, Machado JC, Medeiros R. G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun 2005; 334: 588-592
5. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997; 94: 3195-3199
6. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399
7. Mestiri S, Bouaouina N, Ahmed SB, Khedhaier A, Jrad BB, Remadi S, Chouchane L. Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer 2001; 91: 672-678
8. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro Alves C, Campos ML, Van Doorn LJ, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364-371
9. Liu CJ, Wong YK, Chang KW, Chang HC, Liu HF, Lee YJ. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med 2005; 34: 608-612
10. Tsai FJ, Lu HF, Yeh LS, Hsu CD, Chen WC. Lack of evidence for the association of tumor necrosis factor-alpha gene promoter polymorphism with calcium oxalate stone and bladder cancer patients. Urol Res 2001; 29: 412-416
11. Zheng C, Huang DR, Bergenbrant S, Sundblad A, Osterborg A, Bjorkholm M, Holm G, Yi Q. Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol 2000; 109: 39-45
12. Govan VA, Constant D, Hoffman M, Williamson AL. The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 2006; 6: 24
13. Chinese source
14. Chinese source
15. Zhou JH, Jiang YG. Pre- and postoperative NK cell number and plasma levels of TNF and PGE2 in patients with esophageal carcinoma and their clinical significance. Zhonghua Zhong Liu Za Zhi 1994; 16: 132-136
16. Guo W, Wang N, Li Y, Zhang JH. Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chin Med J (Engl) 2005; 118: 1870-1878
17. Chouchane L, Ahmed SB, Baccouche S, Remadi S. Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 1997; 80: 1489-1496
18. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987; 329: 630-632
19. Balasubramanian SP, Brown NJ, Reed MW. Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer 2002; 87: 1057-1065
20. Semenzato G. Tumour necrosis factor: a cytokine with multiple biological activities. Br J Cancer 1990; 61: 354-361
21. Warren RS, Starnes HF Jr, Alcock N, Calvano S, Brennan MF. Hormonal and metabolic response to recombinant human tumor necrosis factor in rat: in vitro and in vivo. Am J Physiol 1988; 255: E206-E212
22. Nara K, Odagiri H, Fujii M, Yamanaka Y, Yokoyama M, Morita T, Sasaki M, Kon M, Abo T. Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasma. Cancer Immunol Immunother 1987; 25: 126-132
23. Szlosarek P, Charles KA, Balkwill FR. Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer 2006; 42: 745-750
24. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM. TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Inject Dis 2005; 191: 969-976